PT - JOURNAL ARTICLE AU - Chonghaile, Triona Ni AU - Roderick, Justine E. AU - Glenfield, Cian AU - Ryan, Jeremy AU - Sallan, Stephen E. AU - Silverman, Lewis B. AU - Loh, Mignon L. AU - Hunger, Stephen P. AU - Wood, Brent AU - DeAngelo, Daniel J. AU - Stone, Richard AU - Harris, Marian AU - Gutierrez, Alejandro AU - Kelliher, Michelle A. AU - Letai, Anthony TI - Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199 AID - 10.1158/2159-8290.CD-14-0353 DP - 2014 Sep 01 TA - Cancer Discovery PG - 1074--1087 VI - 4 IP - 9 4099 - http://cancerdiscovery.aacrjournals.org/content/4/9/1074.short 4100 - http://cancerdiscovery.aacrjournals.org/content/4/9/1074.full SO - CANCER DISCOVERY2014 Sep 01; 4 AB - Acute lymphoblastic leukemia (ALL) is a hematopoietic malignancy derived from immature B-lymphoid and T-lymphoid cells (T-ALL). In T-ALL, there is an early T-cell progenitor (ETP) subgroup that has a very high risk for relapse. In this study, we used mitochondrial BH3 profiling to determine antiapoptotic protein dependencies in T-ALL. We found that T-ALL cell lines and primary patient samples are dependent upon BCL-XL, except when the cancer bears an ETP phenotype, in which case it is BCL-2 dependent. These distinctions directly relate to differential sensitivity to the BH3 mimetics ABT-263 and ABT-199, both in vitro and in vivo. We thus describe for the first time a change of antiapoptotic protein dependence that is related to the differentiation stage of the leukemic clone. Our findings demonstrate that BCL-2 is a clinically relevant target for therapeutic intervention with ABT-199 in ETP-ALL. Significance: ETP T-ALL is a treatment-resistant subtype of T-ALL for which novel targeted therapies are urgently needed. We have discovered, through BH3 profiling, that ETP-ALL is BCL-2 dependent and is very sensitive to in vitro and in vivo treatment with ABT-199, a drug well tolerated in clinical trials. Cancer Discov; 4(9); 1074–87. ©2014 AACR. This article is highlighted in the In This Issue feature, p. 973